Anju Balakrishnan Selected Research

Atherosclerosis

1/2019	Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.
2/2016	Angiotensinogen Exerts Effects Independent of Angiotensin II.
1/2016	Angiotensin-Converting Enzyme in Smooth Muscle Cells Promotes Atherosclerosis-Brief Report.
1/2016	Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.
8/2015	Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.
1/2013	Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice.
1/2013	Differential effects of dietary sodium intake on blood pressure and atherosclerosis in hypercholesterolemic mice.
1/2012	Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms.
1/2012	Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.
1/2012	Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anju Balakrishnan Research Topics

Disease

10	Abdominal Aortic Aneurysm 01/2020 - 01/2012
10	Atherosclerosis 01/2019 - 01/2012
6	Aortic Aneurysm (Aneurysm, Aortic) 01/2020 - 01/2012
5	Hypercholesterolemia 01/2016 - 01/2012
4	Aneurysm (Aneurysms) 01/2020 - 03/2011
4	Inflammation (Inflammations) 10/2017 - 01/2012
3	Ascending Aorta Aneurysm 01/2015 - 03/2011
2	Infections 11/2022 - 01/2016
2	Body Weight (Weight, Body) 02/2016 - 09/2007
1	Facial Pain (Myofacial Pain) 11/2022
1	Rhinosinusitis 11/2022
1	COVID-19 11/2022
1	Headache (Headaches) 11/2022
1	Fibrosis (Cirrhosis) 10/2017
1	Obesity 10/2017
1	Fatty Liver 02/2016
1	Virus Diseases (Viral Diseases) 02/2016
1	Thoracic Aortic Aneurysm 09/2015
1	Hyperplasia 09/2015
1	Dyslipidemias (Dyslipidemia) 08/2015
1	Rupture 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2014
1	Hypotension (Low Blood Pressure) 01/2013
1	Hypertrophy 01/2013
1	Aortic Rupture 01/2013
1	Bone Resorption 08/2008

Drug/Important Bio-Agent (IBA)

13	Angiotensin IIIBA 05/2017 - 03/2011
8	LDL Receptors (LDL Receptor)IBA 01/2020 - 03/2011
4	CalpainIBA 10/2017 - 01/2012
3	calpastatinIBA 10/2017 - 01/2012
3	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 01/2012
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 01/2016
2	Angiotensin IIBA 01/2020 - 02/2016
2	AngiotensinsIBA 01/2019 - 08/2015
2	Antisense OligonucleotidesIBA 02/2016 - 01/2016
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 05/2015 - 02/2014
2	N- 1- (hydroxy(3- oxo- 2- phenyl- 1- cyclopropen- 1- yl)methyl)- 2- methylpropyl- 2- benzenesulfonylamino- 4- methylpentanamideIBA 01/2013 - 01/2012
2	Messenger RNA (mRNA)IBA 01/2012 - 08/2008
2	Carnitine (L-Carnitine)FDA LinkGeneric 08/2008 - 09/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	Monoclonal AntibodiesIBA 11/2022
1	SteroidsIBA 11/2022
1	ReninIBA 01/2019
1	AngiotensinogenIBA 01/2019
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2019
1	ApolipoproteinsIBA 05/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2017
1	RelaxinIBA 05/2017
1	Renin InhibitorsIBA 02/2016
1	aliskiren FDA Link 02/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Proprotein Convertase 9IBA 01/2016
1	Apolipoproteins B (ApoB)IBA 08/2015
1	Lipoproteins (Lipoprotein)IBA 08/2015
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2015
1	Apolipoproteins E (ApoE)IBA 05/2015
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2015
1	Dietary SodiumIBA 01/2013
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	CalciumIBA 01/2012
1	Cysteine Proteases (Cysteine Protease)IBA 01/2012
1	Alkaline PhosphataseIBA 08/2008
1	CollagenIBA 08/2008
1	Tartrate-Resistant Acid PhosphataseIBA 08/2008
1	Indicators and Reagents (Reagents)IBA 08/2008

Therapy/Procedure

1	Subcutaneous Infusions 09/2015